Basic Xalatan Information

• INN (International Nonproprietary Name): Latanoprost
• Brand Names Available In Australia: not specified
• ATC Code: S01EE01 (S01 = Ophthalmologicals; EE = Prostaglandin Analogues; 01 = Latanoprost)
• Forms & Dosages: Ophthalmic Solution 0.005% (0.05 mg/mL) in 2.5 mL and 5 mL multidose vials; Preservative-free ophthalmic solution 0.005% in single-dose containers
• Manufacturers In Australia: not specified
• Registration Status In Australia: not specified
• OTC / Rx Classification: Prescription only medicine (Rx) in most countries, including US, EU and Japan

Latest Research Highlights

Patients and clinicians ask: is latanoprost still a first choice for glaucoma?

Latanoprost remains a first-line prostaglandin analogue for open‑angle glaucoma and ocular hypertension in recent literature and practice summaries.

Prostaglandin analogues as a class continue to provide the largest intraocular pressure reductions versus older classes in meta‑analyses and comparative trials.

Between‑drug differences are generally modest, though some trials report slightly greater IOP lowering with bimatoprost in selected populations.

Real‑world and trial data report consistent once‑daily IOP lowering with latanoprost 0.005% formulations.

Safety signals are stable and well described, with increased iris pigmentation, eyelash growth and periocular skin darkening among the most common effects.

Uncommon but clinically important events include macular oedema and uveitis, especially where risk factors exist.

A clear formulation trend is growing uptake of preservative‑free products such as Monoprost and Iyuzeh for patients with ocular surface disease.

Registry and regulatory commentary emphasise adherence gaps and the potential benefit of pharmacist‑led counselling to improve outcomes.

Data highlights for preservative‑free uptake: single‑dose preservative‑free options such as Monoprost and Iyuzeh are increasingly used for patients with dry eye or preservative sensitivity.

Clinical Effectiveness In Australia

Do Australian clinics get the same results as the trials?

Clinical practice in Australia follows international evidence and commonly uses latanoprost as the prostaglandin analogue of choice for lowering intraocular pressure in open‑angle glaucoma and ocular hypertension.

Xalatan and generic latanoprost 0.005% are routinely prescribed with once‑daily dosing, usually in the evening.

Shared care between ophthalmology, optometry and primary care achieves sustained IOP control in many patients on monotherapy, although adjunctive therapy is common long term.

TGA adverse‑event monitoring aligns with the global safety profile for latanoprost.

PBS prescribing metrics and hospital outpatient data show high utilisation of prostaglandin analogues in older adults where listed.

Real‑world adherence remains the biggest limiter of effectiveness, with missed doses and incorrect instillation reducing outcomes more than pharmacologic differences between prostaglandins.

Pharmacists and clinicians should prioritise adherence counselling as a key intervention to preserve efficacy in Australian practice.

Indications And Expanded Uses

What is latanoprost officially used for?

• Approved Indication (TGA‑aligned): Reduction of elevated intraocular pressure in open‑angle glaucoma and ocular hypertension using latanoprost ophthalmic solution 0.005%.
• Standard Regimen: One drop in the affected eye(s) once daily, preferably in the evening.

Common Off‑Label Or Expanded Uses In Practice:

• Management of normal‑tension glaucoma under specialist supervision.
• Post‑laser IOP control strategies as part of a clinician‑directed plan.
• Selective paediatric use under specialist care; limited data for patients under 18 years.
• Switching between prostaglandins or to preservative‑free formulations (Monoprost, Iyuzeh) for local tolerability or preservative sensitivity.

Specialist Referral Triggers:

• New or worsening macular oedema risk factors (aphakia, torn posterior capsule).
• Signs of intraocular inflammation or uveitis.
• Suspected herpetic eye disease or unexplained severe ocular pain.

Cross‑check: always confirm current TGA and PBS listings and follow specialist guidance before using latanoprost off‑label.

Composition And Brand Landscape

People often ask which brands are equivalent and what the packaging looks like.

The active ingredient is latanoprost 0.005% (0.05 mg/mL) across products.

Key brands and packaging from the product information include Xalatan (Viatris/Pfizer) in 2.5 mL and 5 mL dropper vials.

Preservative‑free options such as Monoprost and Iyuzeh are supplied in single‑dose containers or single‑use vials.

Generics are produced by multiple global suppliers including Glenmark and Sun Pharma and are usually supplied in 2.5 mL and 5 mL multidose dropper vials.

Pharmacists should confirm the product concentration (0.005%) and preservative status when substituting between brands.

Contraindications And Special Precautions

Who should not use latanoprost, and when should care be taken?

Absolute Contraindications:

• Known hypersensitivity to latanoprost or any component of the formulation.
• History of herpetic keratitis requires specialist consultation before use.

Relative Precautions (Require Monitoring):

• Active intraocular inflammation such as uveitis.
• Aphakia or pseudophakia with a torn posterior lens capsule due to macular oedema risk.
• History of herpetic eye disease.
• Severe asthma — rare bronchospasm reactions have been reported; monitor respiratory status.

Special Australian Considerations:

• Older adults with multiple comorbidities should have ocular and systemic risks reviewed.
• Aboriginal and Torres Strait Islander patients may have higher glaucoma burdens and potential access barriers; follow culturally appropriate care pathways.
• Pregnancy and breastfeeding data are limited; discuss risk versus benefit with the treating specialist.

Daily‑Life Restrictions:

• Avoid driving until vision is clear after instillation if blurred vision occurs.
• Counsel patients performing safety‑sensitive work if transient blurring may pose risk.

Dosage Guidelines

How should patients use latanoprost for best results?

Standard Australian Regimen: One drop of 0.005% latanoprost in the affected eye(s) once daily, ideally in the evening.

Do not increase frequency: dosing more than once daily does not improve IOP control and may reduce efficacy.

Administration Notes:

• Wait at least five minutes between separate topical ophthalmic medicines.
• Remove contact lenses before instillation and wait 15 minutes before reinserting lenses unless product advice differs.
• Paediatric dosing is limited and should be prescribed by a specialist.
• No routine dose adjustment for elderly patients is required.

Storage And Handling:

• Store refrigerated at 2–8°C before opening.
• After opening, store below 25°C, protect from light and discard after 4–6 weeks per labelling.
• Single‑dose preservative‑free vials have prescribed handling and should be used per product instructions.

Missed Dose Advice: Give the missed dose on the same day when remembered; do not double up the next dose.

Interactions Overview

Will latanoprost interact with other medicines?

Systemic drug interactions are minimal owing to low systemic absorption of topical latanoprost.

Important Interaction Considerations:

• Separate administration of concomitant topical glaucoma agents by at least five minutes to avoid washout.
• Benzalkonium chloride in other eye drops may affect tolerability and ocular surface health when used with latanoprost-containing formulations.
• Avoid concurrent use with other prostaglandin analogues.
• Rare bronchospasm reports mean monitor patients with severe asthma; consult prescriber if respiratory symptoms occur.

Cultural Perceptions And Patient Habits

What do Australian patients worry about with Xalatan?

Patients balance clinical advice against cost, convenience and trust in pharmacists when choosing glaucoma therapy.

Common Perceptions:

• Prostaglandin drops are recognised as effective, but cosmetic changes such as iris darkening and eyelash growth concern some users.
• Price sensitivity leads many patients to rely on PBS subsidies where available or to shop at discount chains such as Chemist Warehouse.
• Many patients value in‑person pharmacist counselling at TerryWhite Chemmart or Priceline, and telehealth e‑prescriptions are increasingly used.

Access And Rural Considerations:

• Rural and remote communities face supply continuity and cold‑chain storage issues for refrigerated multidose bottles before opening.
• Telehealth and mail‑order pharmacy solutions help but require clear instructions for refrigerated transport.
• Indigenous health services should be engaged for culturally safe, community‑based follow‑up, given the higher glaucoma prevalence among Aboriginal and Torres Strait Islander peoples.

Patient Habits: Online forums commonly mention forgetting evening doses and interest in preservative‑free formats to reduce irritation.

Availability And Pricing Patterns

Where can patients buy Xalatan and how much will it cost?

Xalatan and generics 0.005% are widely stocked across Australian pharmacies, though exact brand availability and preservative‑free options vary by store.

Major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart commonly supply generics and brand alternatives.

Smaller rural pharmacies may need to order specific preservative‑free packs or single‑dose vials for patients.

Pricing Patterns:

• PBS listing where applicable can substantially reduce patient cost; check the current PBS schedule and eligibility for subsidy.
• Private pricing varies across community and online pharmacies.
• Telehealth e‑prescriptions and online pharmacies offer convenience but check cold‑chain handling for refrigerated stock before opening.

Logistics Note: Single‑dose preservative‑free vials are easier to ship without refrigeration than multidose refrigerated bottles prior to opening.

Purchase Context: In our online pharmacy, xalatan is available without a prescription, with discreet delivery to Australia in 5-14 days.

Comparable Medicines And Preferences

What are the reasonable alternatives to latanoprost in Australia?

Other prostaglandin analogues include bimatoprost (Lumigan), travoprost (Travatan Z) and tafluprost (Saflutan), with some available in preservative‑free forms.

Comparative Considerations:

• Efficacy across prostaglandin analogues is broadly similar, with marginal differences; some trials show slightly greater IOP lowering with bimatoprost in specific settings.
• Tolerability and cosmetic effects differ between agents and may guide individual choice.
• Preservative‑free tafluprost or tafluprost‑class options may suit those with ocular surface disease.
• PBS listing and out‑of‑pocket cost often influence selection in Australia.

FAQ

Can I buy Xalatan without a prescription?

No — latanoprost is prescription‑only in most jurisdictions, and a prescriber should advise treatment and monitoring.

How long until I see an effect?

IOP lowering is measurable within days, with full effect often apparent within two to four weeks; ongoing follow‑up is essential to confirm target IOP.

Will it change my eye colour?

Increased iris pigmentation is a recognised effect and may be permanent in some patients; discuss cosmetic concerns before starting therapy.

Can I use contact lenses?

Remove contact lenses before instillation and wait approximately 15 minutes before reinserting; single‑dose preservative‑free formats may be preferable for lens wearers.

Guidelines For Proper Use

What should pharmacists say when counselling a patient starting latanoprost?

• Confirm the indication, prescription details and check for known allergies or history of herpetic eye disease or uveitis.
• Demonstrate instillation: tilt head back, pull the lower lid down, instil one drop, close the eye gently for 1–2 minutes and apply nasolacrimal occlusion to reduce systemic absorption.
• Advise waiting five minutes between different eye drops.
• Storage: refrigerate 2–8°C before opening; after opening store below 25°C and discard after 4–6 weeks per product labelling.
• Single‑dose preservative‑free vials have different handling — follow the product leaflet.
• Side‑effect counselling: expect mild irritation, eyelash changes and possible iris darkening; advise urgent review for marked pain, sudden vision loss, or signs of uveitis or macular oedema.
• Follow‑up: schedule IOP checks and ocular surface reviews; consider switching to preservative‑free options if intolerance occurs.

Quick Counselling Script For Pharmacists:

“This drop is one drop into the affected eye at night.

Do not exceed once daily.

Remove lenses first and wait 15 minutes after dosing.

Keep the bottle refrigerated until opened and discard after the period on the label.

Report any sudden vision changes or severe eye pain promptly.”

Delivery Across Australia